查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1507198

MCED（多种癌症早期检测）市场、占有率、规模、趋势、行业分析报告、预测，2024-2032年

Multi Cancer Early Detection Market Share, Size, Trends, Industry Analysis Report Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年，全球MCED（多种癌症早期检测）市场规模将达到39.3479亿美元。本研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于基因组学、生物技术和人工智慧的进步，MCED（多种癌症早期检测）市场迅速发展。该市场致力于诊断测试的开发和商业化，这些测试可以从单一样本中检测多种癌症类型，通常使用血液测试等非侵入性方法。其目的是在早期可治疗阶段发现癌症，改善患者治疗效果并降低医疗费用。

有几个因素推动了多种癌症早期检测市场的成长。首先，全球癌症发生率不断上升，以及人们对早期检测益处的认识不断提高，刺激了对创新诊断解决方案的需求。据世界卫生组织（WHO）表示，癌症是全球头号死亡原因，预计未来20年新发病例将增加约 60%。其次，基因组学和分子生物学的技术进步开发敏感且特异的生物标记，可以及早发现癌症。公司利用这些进步来开发多种癌症筛检测试，这些测试可以纳入常规临床实践。

此外，公共和私营部门对研发的大量投资加快该领域的创新步伐。各国政府和卫生组织也日益支持早期检测举措，认识到其拯救生命和减少长期医疗保健支出的潜力。此外，个人化医疗的普及和向预防性护理的转变推动 MCED（多种癌症早期检测）测试整合到更广泛的筛检计划中。综合考虑这些驱动因素，MCED（多癌症早期检测）市场预计在未来几年将显着成长，并改变癌症诊断和患者护理。

MCED（多种癌症早期检测）市场报告亮点

由于液体活检的研究不断增加，液体活检领域预计将以最快的年复合成长率成长。

由于个人化医疗意识不断增强以及对负担得起的服务的需求不断成长，诊断实验室行业预计将快速成长

由于癌症患者数量不断增加以及提高生存率的需求不断成长，预计亚太地区将出现显着成长

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 洞察全球 MCED（多种癌症早期检测）市场

  • 行业概况
  • MCED（多发性癌症早期检测）市场动态
    • 推动因素和机会
      • 多种癌症早期检测（MCED）测试透过人工智慧整合改变癌症筛检
      • 提高癌症检出率
    • 抑制因素和挑战
      • 围绕 MCED（多种癌症早期检测）检测的潜在风险和不确定性
  • 波特五力分析
  • PESTLE分析
  • MCED（多种癌症早期检测）产业的趋势
  • 价值链分析
  • 新冠肺炎（COVID-19）影响分析

第5章 全球 MCED（多种癌症早期检测）市场：依类型

  • 主要发现
  • 简介
  • 液体活检
  • 基因组，LDT
  • 其他

第6章 全球 MCED（多种癌症早期检测）市场：依最终用户

  • 主要发现
  • 简介
  • 医院
  • 诊断实验室
  • 其他

第7章 全球 MCED（多种癌症早期检测）市场：地区

  • 主要发现
  • 简介
    • MCED（多种癌症早期检测）市场评估：地区，2019-2032年
  • 北美
    • 北美：依最终使用者，2019-2032年
    • 北美：依类型，2019-2032年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依最终使用者，2019-2032年
    • 欧洲：依类型，2019-2032年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区：依最终使用者，2019-2032年
    • 亚太地区：依类型，2019-2032年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
  • 中东、非洲
    • 中东和非洲：依最终用户，2019-2032年
    • 中东、非洲：依类型，2019-2032年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依最终使用者，2019-2032年
    • 拉丁美洲：依类型，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第8章 竞争态势

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协定/揭露

第9章 公司简介

  • Illumina, Inc.（GRAIL, LLC）
  • Exact Sciences Corp.
  • Foundation Medicine, Inc
  • AnchorDx
  • Guardant Health
  • Burning Rock Biotech Ltd
  • GENECAST
  • Beijing Lyman Juntai International Medical Technology Development Co
  • Freenome Holdings, Inc.
  • Elypta AB
Product Code: PM4952

The global multi cancer early detection market size is expected to reach USD 3,934.79 million by 2032, according to a new study by Polaris Market Research. The report "Multi Cancer Early Detection Market Size, Share & Trends Analysis Report, By Type (Liquid Biopsy, Gene Panel, LDT & Others), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The multi-cancer early detection market is rapidly evolving, driven by advances in genomics, biotechnology, and artificial intelligence. This market focuses on the development and commercialization of diagnostic tests capable of detecting multiple cancer types from a single sample, often using non-invasive methods such as blood tests. The aim is to identify cancer at an early, more treatable stage, improving patient outcomes and reducing healthcare costs.

Several factors are driving the growth of the multi-cancer early detection market. Firstly, the increasing global incidence of cancer, coupled with the rising awareness of the benefits of early detection, fuels demand for innovative diagnostic solutions. According to the World Health Organization, cancer is a leading cause of death worldwide, with new cases expected to rise by approximately 60% over the next two decades. Secondly, technological advancements in genomics and molecular biology have led to the development of highly sensitive and specific biomarkers that can detect cancer at very early stages. Companies are leveraging these advancements to create multi-cancer screening tests that can be integrated into routine clinical practice.

Additionally, substantial investments in research and development by both private and public sectors are accelerating the pace of innovation in this field. Governments and health organizations are also increasingly supporting early detection initiatives, recognizing their potential to save lives and reduce long-term healthcare expenditures. Furthermore, the growing adoption of personalized medicine and the shift towards preventive healthcare are encouraging the integration of multi-cancer early detection tests into broader health screening programs. Collectively, these driving factors position the multi-cancer early detection market for significant growth in the coming years, promising to transform cancer diagnostics and patient care.

Multi Cancer Early Detection Market Report Highlights

The liquid biopsy segment is anticipated to grow at the fastest CAGR, owing rise in research towards liquid biopsies

The diagnostic laboratories segment will grow with rapid pace, due to the increased awareness of personalized medicine, rise in demand for affordable services

APAC expected to witness substantial growth rate, due to rising number of cancer cases and rising need to increase survival rate

The global players include Illumina, Sciences Corp., Foundation Medicine, AnchorDxFreewomen, and Elypta

Polaris Market Research has segmented the Multi Cancer Early Detection Market report based on type, end use, and region:

Multi Cancer Early Detection, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Liquid Biopsy
  • Gene Panel, LDT & Others

Multi Cancer Early Detection End-use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Diagnostic Laboratories
  • Other

Multi Cancer Early Detection, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Multi Cancer Early Detection Market Insights

  • 4.1. Multi Cancer Early Detection Market - Industry Snapshot
  • 4.2. Multi Cancer Early Detection Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Multi-Cancer Early Detection (MCED) Tests Transforming Cancer Screening with AI Integration
      • 4.2.1.2. Enhancing Cancer Detection Rates
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Potential Risks and Uncertainties Surrounding Multi-Cancer Early Detection Tests
  • 4.3. Porter's Five Forces Analysis<
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Multi Cancer Early Detection Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Multi Cancer Early Detection Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Multi Cancer Early Detection, by Type, 2019-2032 (USD Million)
  • 5.3. Liquid Biopsy
    • 5.3.1. Global Multi Cancer Early Detection Market, by Liquid Biopsy, by Region, 2019-2032 (USD Million)
  • 5.4. Gene Panel, LDT
    • 5.4.1. Global Multi Cancer Early Detection Market, by Gene Panel, LDT, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Multi Cancer Early Detection Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Multi Cancer Early Detection Market, by End User

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Multi Cancer Early Detection Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 6.4. Diagnostic Laboratories
    • 6.4.1. Global Multi Cancer Early Detection Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Multi Cancer Early Detection Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Multi Cancer Early Detection Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Multi Cancer Early Detection Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Multi Cancer Early Detection Market - North America
    • 7.3.1. North America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.3.2. North America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.3.3. Multi Cancer Early Detection Market - U.S.
      • 7.3.3.1. U.S.: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.3.4. Multi Cancer Early Detection Market - Canada
      • 7.3.4.1. Canada: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.4. Multi Cancer Early Detection Market - Europe
    • 7.4.1. Europe: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.4.2. Europe: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.3. Multi Cancer Early Detection Market - UK
      • 7.4.3.1. UK: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.4. Multi Cancer Early Detection Market - France
      • 7.4.4.1. France: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.4.2. France: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.5. Multi Cancer Early Detection Market - Germany
      • 7.4.5.1. Germany: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.6. Multi Cancer Early Detection Market - Italy
      • 7.4.6.1. Italy: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.7. Multi Cancer Early Detection Market - Spain
      • 7.4.7.1. Spain: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.8. Multi Cancer Early Detection Market - Netherlands
      • 7.4.8.1. Netherlands: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.9. Multi Cancer Early Detection Market - Russia
      • 7.4.9.1. Russia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.5. Multi Cancer Early Detection Market - Asia Pacific
    • 7.5.1. Asia Pacific: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.3. Multi Cancer Early Detection Market - China
      • 7.5.3.1. China: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.3.2. China: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.4. Multi Cancer Early Detection Market - India
      • 7.5.4.1. India: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.4.2. India: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.5. Multi Cancer Early Detection Market - Malaysia
      • 7.5.5.1. Malaysia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.6. Multi Cancer Early Detection Market - Japan
      • 7.5.6.1. Japan: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.7. Multi Cancer Early Detection Market - Indonesia
      • 7.5.7.1. Indonesia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.8. Multi Cancer Early Detection Market - South Korea
      • 7.5.8.1. South Korea: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.6. Multi Cancer Early Detection Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.3. Multi Cancer Early Detection Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.4. Multi Cancer Early Detection Market - UAE
      • 7.6.4.1. UAE: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.5. Multi Cancer Early Detection Market - Israel
      • 7.6.5.1. Israel: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.6. Multi Cancer Early Detection Market - South Africa
      • 7.6.6.1. South Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.7. Multi Cancer Early Detection Market - Latin America
    • 7.7.1. Latin America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.7.3. Multi Cancer Early Detection Market - Mexico
      • 7.7.3.1. Mexico: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.7.4. Multi Cancer Early Detection Market - Brazil
      • 7.7.4.1. Brazil: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.7.5. Multi Cancer Early Detection Market - Argentina
      • 7.7.5.1. Argentina: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Illumina, Inc. (GRAIL, LLC)
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Exact Sciences Corp.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Foundation Medicine, Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. AnchorDx
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Guardant Health
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Burning Rock Biotech Ltd
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. GENECAST
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Beijing Lyman Juntai International Medical Technology Development Co
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Freenome Holdings, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Elypta AB
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables

  • Table 1 Global Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 2 Global Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 3 Multi Cancer Early Detection Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 5 North America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 6 U.S.: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 7 U.S.: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 8 Canada: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 9 Canada: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 10 Europe: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 11 Europe: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 12 UK: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 13 UK: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 14 France: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 15 France: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 16 Germany: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 17 Germany: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 18 Italy: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 19 Italy: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 20 Spain: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 21 Spain: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 22 Netherlands: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 23 Netherlands: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 24 Russia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 25 Russia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 28 China: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 29 China: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 30 India: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 31 India: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 32 Malaysia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 33 Malaysia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 34 Japan: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 35 Japan: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 36 Indonesia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 37 Indonesia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 38 South Korea: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 39 South Korea: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 44 UAE: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 45 UAE: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 46 Israel: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 47 Israel: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 48 South Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 49 South Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 50 Latin America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 51 Latin America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 52 Mexico: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 53 Mexico: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 54 Brazil: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 55 Brazil: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 56 Argentina: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 57 Argentina: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Multi Cancer Early Detection Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End User
  • Figure 7 Global Multi Cancer Early Detection Market, by End User, 2022 & 2032 (USD Million)
  • Figure 8 Market by Type
  • Figure 9 Global Multi Cancer Early Detection Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10 Multi Cancer Early Detection Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Multi Cancer Early Detection Market